Change - Announcement of Appointment::Appointment of Group Chief Executive Officer

Issuer & Securities

Issuer/ Manager
AURIC PACIFIC GROUP LIMITED
Securities
AURIC PACIFIC GROUP LIMITED - SG1B49001004 - A23
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
09-May-2016 18:27:03
Status
New
Announcement Sub Title
Appointment of Group Chief Executive Officer
Announcement Reference
SG160509OTHRO5VB
Submitted By (Co./ Ind. Name)
Adrian Chan Pengee
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Appointment of Group Chief Executive Officer

Additional Details

Date Of Appointment
09/05/2016
Name Of Person
Dr Andy Adhiwana
Age
31
Country Of Principal Residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process)
The Board has approved Dr Adhiwana to be appointed as Group Chief Executive Officer, with Dr. Stephen Riady and Dr. Adhiwana abstaining. The Board, after taking into consideration Dr Adhiwana's qualifications, experience, track record within the Group, and familiarity with the Group's business, is of the view that his appointment as Group Chief Executive Officer is in the best interest of the Group.

Dr Adhiwana graduated from the renowned Heidelberg University and earned a Bachelor of Medicine, Bachelor of Surgery and a Doctorate in Medicine, where he distinguished himself and was granted the prestigious "Dr.med." title with cum laude.

Notwithstanding his distinction in medicine, Dr Adhiwana pursued his interest in business and enrolled, in the Master of Business Administration programme with the National University of Singapore, and was subsequently awarded a Master of Business Administration degree.
Whether appointment is executive, and if so, the area of responsibility
Executive. In his new appointment Dr Adhiwana will be responsible for overall strategic development, management and operations of the Group.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Group Chief Executive Officer
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Son-in-law of Dr Stephen Riady, an Executive Director and substantial shareholder of the Company
Conflict of interests (including any competing business)
None
Working experience and occupation(s) during the past 10 years
Business Development Manager at Auric Pacific Group Limited
(December 2013 to October 2014)
Executive Director of Auric Pacific Group Limited
(November 2014 to Present)
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
Dr Andy Adhiwana is the beneficial owner of the entire issued share capital of Bravado International Ltd. ("Bravado"). He is deemed to be interested in the shares of Auric Pacific Group Limited ("APGL") through Bravado, which in turn has a 24.89% deemed interest in the shares of APGL held by Goldstream Capital Limited, a wholly owned subsidiary of Bravado.
Other Directorships
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
Nil
Present
Stand Capital Pte. Ltd.
Auric Pacific Group Limited
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Disclosure applicable to the appointment of Director only.
Any prior experience as a director of a listed company?
No
If No, Please provide details of any training undertaken in the roles and responsibilities of a director of a listed company
N/A

Attachments

Appointment of Dr Andy Adhiwana as Group Chief Executive Officer.pdf
Total size =182K